BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 19177349)

  • 1. Conformational changes within the HLA-A1:MAGE-A1 complex induced by binding of a recombinant antibody fragment with TCR-like specificity.
    Kumar P; Vahedi-Faridi A; Saenger W; Ziegler A; Uchanska-Ziegler B
    Protein Sci; 2009 Jan; 18(1):37-49. PubMed ID: 19177349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A major histocompatibility complex-peptide-restricted antibody and t cell receptor molecules recognize their target by distinct binding modes: crystal structure of human leukocyte antigen (HLA)-A1-MAGE-A1 in complex with FAB-HYB3.
    Hülsmeyer M; Chames P; Hillig RC; Stanfield RL; Held G; Coulie PG; Alings C; Wille G; Saenger W; Uchanska-Ziegler B; Hoogenboom HR; Ziegler A
    J Biol Chem; 2005 Jan; 280(4):2972-80. PubMed ID: 15537658
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal and recombinant antibodies with T cell receptor-like reactivity.
    Ziegler A; Coulie PG; Uchańska-Ziegler B
    Recent Results Cancer Res; 2007; 176():229-41. PubMed ID: 17607930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct selection of a human antibody fragment directed against the tumor T-cell epitope HLA-A1-MAGE-A1 from a nonimmunized phage-Fab library.
    Chames P; Hufton SE; Coulie PG; Uchanska-Ziegler B; Hoogenboom HR
    Proc Natl Acad Sci U S A; 2000 Jul; 97(14):7969-74. PubMed ID: 10884427
    [TBL] [Abstract][Full Text] [Related]  

  • 5. How a T cell receptor-like antibody recognizes major histocompatibility complex-bound peptide.
    Mareeva T; Martinez-Hackert E; Sykulev Y
    J Biol Chem; 2008 Oct; 283(43):29053-9. PubMed ID: 18703505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TCR-like human antibodies expressed on human CTLs mediate antibody affinity-dependent cytolytic activity.
    Chames P; Willemsen RA; Rojas G; Dieckmann D; Rem L; Schuler G; Bolhuis RL; Hoogenboom HR
    J Immunol; 2002 Jul; 169(2):1110-8. PubMed ID: 12097420
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T cell retargeting with MHC class I-restricted antibodies: the CD28 costimulatory domain enhances antigen-specific cytotoxicity and cytokine production.
    Willemsen RA; Ronteltap C; Chames P; Debets R; Bolhuis RL
    J Immunol; 2005 Jun; 174(12):7853-8. PubMed ID: 15944290
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redirecting human CD4+ T lymphocytes to the MHC class I-restricted melanoma antigen MAGE-A1 by TCR alphabeta gene transfer requires CD8alpha.
    Willemsen R; Ronteltap C; Heuveling M; Debets R; Bolhuis R
    Gene Ther; 2005 Jan; 12(2):140-6. PubMed ID: 15496961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification of a tumor-derived peptide at an HLA-A2 anchor residue can alter the conformation of the MHC-peptide complex: probing with TCR-like recombinant antibodies.
    Denkberg G; Klechevsky E; Reiter Y
    J Immunol; 2002 Oct; 169(8):4399-407. PubMed ID: 12370373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural basis for the presentation of tumor-associated MHC class II-restricted phosphopeptides to CD4+ T cells.
    Li Y; Depontieu FR; Sidney J; Salay TM; Engelhard VH; Hunt DF; Sette A; Topalian SL; Mariuzza RA
    J Mol Biol; 2010 Jun; 399(4):596-603. PubMed ID: 20417641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of naturally processed and HLA-A1-presented melanoma T-cell epitopes defined by CD8(+) T-cells' release of granulocyte-macrophage colony-stimulating factor but not by cytolysis.
    Maeurer MJ; Martin D; Elder E; Storkus WJ; Lotze MT
    Clin Cancer Res; 1996 Jan; 2(1):87-95. PubMed ID: 9816095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction and binding analysis of recombinant single-chain TCR derived from tumor-infiltrating lymphocytes and a cytotoxic T lymphocyte clone directed against MAGE-1.
    Lake DF; Salgaller ML; van der Bruggen P; Bernstein RM; Marchalonis JJ
    Int Immunol; 1999 May; 11(5):745-51. PubMed ID: 10330280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High-resolution structure of HLA-A*0201 in complex with a tumour-specific antigenic peptide encoded by the MAGE-A4 gene.
    Hillig RC; Coulie PG; Stroobant V; Saenger W; Ziegler A; Hülsmeyer M
    J Mol Biol; 2001 Jul; 310(5):1167-76. PubMed ID: 11502003
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A phage display selected fab fragment with MHC class I-restricted specificity for MAGE-A1 allows for retargeting of primary human T lymphocytes.
    Willemsen RA; Debets R; Hart E; Hoogenboom HR; Bolhuis RL; Chames P
    Gene Ther; 2001 Nov; 8(21):1601-8. PubMed ID: 11894998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. T cell receptor interactions with human leukocyte antigen govern indirect peptide selectivity for the cancer testis antigen MAGE-A4.
    Coles CH; McMurran C; Lloyd A; Hock M; Hibbert L; Raman MCC; Hayes C; Lupardus P; Cole DK; Harper S
    J Biol Chem; 2020 Aug; 295(33):11486-11494. PubMed ID: 32532817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HLA photoaffinity labeling reveals overlapping binding of homologous melanoma-associated gene peptides by HLA-A1, HLA-A29, and HLA-B44.
    Luescher IF; Romero P; Kuznetsov D; Rimoldi D; Coulie P; Cerottini JC; Jongeneel CV
    J Biol Chem; 1996 May; 271(21):12463-71. PubMed ID: 8647853
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting melanoma with immunoliposomes coupled to anti-MAGE A1 TCR-like single-chain antibody.
    Saeed M; van Brakel M; Zalba S; Schooten E; Rens JA; Koning GA; Debets R; Ten Hagen TL
    Int J Nanomedicine; 2016; 11():955-75. PubMed ID: 27022262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fab antibodies capable of blocking T cells by competitive binding have the identical specificity but a higher affinity to the MHC-peptide-complex than the T cell receptor.
    Neumann F; Sturm C; Hülsmeyer M; Dauth N; Guillaume P; Luescher IF; Pfreundschuh M; Held G
    Immunol Lett; 2009 Aug; 125(2):86-92. PubMed ID: 19524620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Strict Assembly Restriction of Peptides from Rabbit Hemorrhagic Disease Virus Presented by Rabbit Major Histocompatibility Complex Class I Molecule RLA-A1.
    Zhang Q; Liu K; Yue C; Zhang D; Lu D; Xiao W; Liu P; Zhao Y; Gao G; Ding C; Lyu J; Liu WJ
    J Virol; 2020 Aug; 94(17):. PubMed ID: 32522857
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structures of MART-126/27-35 Peptide/HLA-A2 complexes reveal a remarkable disconnect between antigen structural homology and T cell recognition.
    Borbulevych OY; Insaidoo FK; Baxter TK; Powell DJ; Johnson LA; Restifo NP; Baker BM
    J Mol Biol; 2007 Oct; 372(5):1123-36. PubMed ID: 17719062
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.